Articles

Articles

Open AccessReview

The Role of Autophagy and Potential Drug Targets in Cardiovascular Disease

Vaseega Sathianandan, Tayyiba Azam

2026, 5(3): 100016. doi: 10.53941/ijddp.2026.100016

25 Downloaded
208 Viewed
Download PDF
Open AccessEditorial

Nucleolar Stress: An Emerging Avenue for Cardiovascular Drug Target Identification

Tayyiba Azam, Xin Wang

2026, 5(1): 100007. doi: 10.53941/ijddp.2026.100007

39 Downloaded
271 Viewed
Download PDF
Open AccessReview
Integrins as Drug Targets in Vascular and Related Diseases

Emily Meredith, Martin A. Schwartz

2024, 3(2): 100010. doi: 10.53941/ijddp.2024.100010

28 Downloaded
188 Viewed
3 Cited
Download PDF
Open AccessReview
Transforming Growth Factor β Signaling Pathway as a Potential Drug Target in Treating Aortic Diseases

Zijie Liu, Tianyu Song, Liping Xie

2024, 3(1): 100003. doi: 10.53941/ijddp.2024.100003

40 Downloaded
266 Viewed
1 Cited
Download PDF
Open AccessExpert review
p21-Activated Kinases Present a New Drug Target for Hypertrophic Cardiomyopathy

Yu He, Ming Lei

2023, 2(3): 79–86. doi: 10.53941/ijddp.2023.100006

24 Downloaded
147 Viewed
2 Cited
Download PDF
Open AccessReview
Mechanism of Anti-seizure Medications and Emerging Trends in Epilepsy Treatment

Zubin Singh Rana, Reena Suman, Shobi Veleri, Pradeep Punnakkal

2023, 2(2): 1–16. doi: 10.53941/ijddp.2023.100001

124 Downloaded
471 Viewed
14 Cited
Download PDF
Open AccessEditorial
Current Progress in Drug Target Identification and Drug Delivery

Xin Wang

2022, 1(1): 1. doi: 10.53941/ijddp.v1i1.214

24 Downloaded
105 Viewed
Download PDF
Open AccessReview
The Hippo Signaling Pathway as a Drug Target in Familial Dilated Cardiomyopathy

Paulina Langa, Beata M. Wolska, R. John Solaro

2022, 1(1): 4. doi: 10.53941/ijddp.v1i1.189

14 Downloaded
92 Viewed
7 Cited
Download PDF